Biotech Values

[DewDiligence]

TEVA seems too big in its own country to become second fiddle to someone elsewhere.

I concur and posted about this in #msg-94495284. Nevertheless, I included Teva in the 2014 buyout survey because Bloomberg and other newswires have penned pieces that quoted analysts who said Teva is a likely buyout candidate in light of the recent palace coup.